LEADER 01553nas  22004933  450 
001 996204782703316
005 20221206193531.0
011   $a2377-6625
035   $a(OCoLC)50326407
035   $a(CKB)111020957594036
035   $a(CONSER)--2015201790
035   $a(EXLCZ)99111020957594036
100   $a20020808b20002003  ---         a
101 0 $aeng
135   $aurmnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aPharmaceutical innovation
210  1$aMontclair, N.J. :$cAdis International, Inc.
311   $a1537-1328 
531 0 $aPharm. innov.
606   $aPharmaceutical technology$vPeriodicals
606   $aPharmaceutical industry$vPeriodicals
606   $aGene therapy$vPeriodicals
606   $aAntisense nucleic acids$vPeriodicals
606   $aAntisense nucleic acids$2fast$3(OCoLC)fst00810788
606   $aGene therapy$2fast$3(OCoLC)fst00939638
606   $aPharmaceutical industry$2fast$3(OCoLC)fst01060129
606   $aPharmaceutical technology$2fast$3(OCoLC)fst01060211
608   $aPeriodicals.$2fast
615  0$aPharmaceutical technology
615  0$aPharmaceutical industry
615  0$aGene therapy
615  0$aAntisense nucleic acids
615  7$aAntisense nucleic acids.
615  7$aGene therapy.
615  7$aPharmaceutical industry.
615  7$aPharmaceutical technology.
676   $a338
906   $aJOURNAL
912   $a996204782703316
996   $aPharmaceutical innovation$92493629
997   $aUNISA